John Kinzell
Principal investigator, leads Xeris Pharmaceuticals, Inc..
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$514KFederal grants as PI1 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
1 awards · $514K
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 25, 2015 | NIH | SBIR Phase II Auto-Injectable Diazepam Formulation for Rapid Treatment of Uncontrolled Seizures | $514K | Xeris Pharmaceuticals, Inc. |
Peer ranks
Federal funding#2,376
Awards as PI#2,176
Patents#273
Companies
- Xeris Pharmaceuticals, Inc.Leads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.